Sugi Predict

Sugi Predict / Compounds / SCHEMBL2733286

SCHEMBL2733286

SCHEMBL2733286

CC(C)(C)c1cc(CO)no1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.45
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NOTUM Q6P988 2/20 0.43
▸ HPGD P15428 1/20 0.43
▸ NPC1 O15118 4/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MAPK14 Q16539 2/20 0.37
▸ EPHX2 P34913 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3770253 0.86 NOTUM (0.42) EGFRMEN1KMT2ANOTUMHPGD
SCHEMBL3761219 0.84 NOTUM (0.41) EGFRMEN1KMT2ANOTUMHPGD
SCHEMBL25799448 0.82 NOTUM (0.40) EGFRNOTUMHPGD
SCHEMBL9610944 0.81 MEN1 (0.44) EGFRMEN1KMT2AHPGDNPC1
SCHEMBL2810801 0.79 EGFR (0.49) EGFRMEN1KMT2AHPGDNPC1
SCHEMBL19179708 0.79 MEN1 (0.43) EGFRMEN1KMT2AHPGDNPC1
SCHEMBL411505 0.79 NOTUM (0.43) NOTUMCNR1CNR2
SCHEMBL14067390 0.78 NOTUM (0.37) NOTUM
SCHEMBL12203125 0.78 MEN1 (0.42) EGFRMEN1KMT2AHPGDNPC1
SCHEMBL21672545 0.76 EGFR (0.42) EGFRMEN1KMT2AHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713321-B2 Inhibitors of NEK7 kinase Halia Therapeutics, Inc. (US) 2023-08-01 — — US disclosed
US-20230210853-A1 TARGETED NEK7 INHIBITION FOR MODULATION OF THE NLRP3 INFLAMMASOME Halia Therapeutics, Inc. 2023-07-06 — — US disclosed
US-20230210853-A1 TARGETED NEK7 INHIBITION FOR MODULATION OF THE NLRP3 INFLAMMASOME Halia Therapeutics, Inc. 2023-07-06 — — US disclosed
US-20230203045-A1 INHIBITORS OF NEK7 KINASE Halia Therapeutics, Inc. 2023-06-29 — — US disclosed
US-11161852-B1 Inhibitors of NEK7 kinase Halia Therapeutics, Inc. (US) 2021-11-02 — — US disclosed
EP-3210969-B1 KCNQ2-5 CHANNEL ACTIVATOR ONO PHARMACEUTICAL CO (JP) 2021-04-28 — — EP disclosed
CN-107108485-B KCNQ 2-5 channel activator 小野药品工业株式会社 2020-06-12 — — CN disclosed
US-10676438-B2 KCNQ2-5 channel activator ONO PHARMACEUTICAL CO., LTD. (JP) 2020-06-09 — — US disclosed
US-20200157050-A1 KCNQ2-5 CHANNEL ACTIVATOR ONO PHARMACEUTICAL CO., LTD. (JP) 2020-05-21 — — US disclosed
US-10570093-B2 — — 2020-02-25 — — US disclosed
US-7846956-B2 Malononitrile compound as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-07 — — US disclosed
US-20090149425-A1 Malononitrile compound as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-11 — — US disclosed
US-20090149425-A1 Malononitrile compound as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-11 — — US disclosed
US-20090149425-A1 Malononitrile compound as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-11 — — US disclosed
EP-1704143-B1 MALONONITRILE COMPOUND AS PESTICIDES SUMITOMO CHEMICAL CO (JP) 2008-09-03 — — EP disclosed
EP-1704143-B1 MALONONITRILE COMPOUND AS PESTICIDES SUMITOMO CHEMICAL CO (JP) 2008-09-03 — — EP disclosed
US-20070213330-A1 Anticancer agents; antiproliferative agents METHYLGENE INC. (CA) 2007-09-13 — — US disclosed
US-7253204-B2 Antiproliferative agents METHYLGENE INC. (CA) 2007-08-07 — — US disclosed
EP-1704143-A1 MALONONITRILE COMPOUND AS PESTICIDES Sumitomo Chemical Company, Limited (JP) 2006-09-27 — — EP disclosed
WO-2005068432-A1 MALONONITRILE COMPOUND AS PESTICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-07-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203045-A1 INHIBITORS OF NEK7 KINASE NEK7, NEK1, NEK5 EGFR 4664/4885MEN1 1800/4885KMT2A 2881/4885
US-11713321-B2 Inhibitors of NEK7 kinase NEK7, NEK1, NEK5 EGFR 4553/4885MEN1 1766/4885KMT2A 2554/4885
US-20070213330-A1 Anticancer agents; antiproliferative agents HDAC1, HDAC11, HDAC5 EGFR 1289/4885MEN1 2386/4885KMT2A 68/4885
US-20230210853-A1 TARGETED NEK7 INHIBITION FOR MODULATION OF THE NLRP3 INFLAMMASOME NEK7, NLRP3, NOD1 EGFR 4872/4885MEN1 3098/4885KMT2A 4530/4885
US-10570093-B2 — KCNQ5, KCNQ2, KCNQ1 EGFR 4848/4885MEN1 899/4885KMT2A 917/4885
US-20200157050-A1 KCNQ2-5 CHANNEL ACTIVATOR KCNQ5, KCNQ2, KCNQ1 EGFR 4717/4885MEN1 1445/4885KMT2A 515/4885
US-11161852-B1 Inhibitors of NEK7 kinase NEK7, NEK1, NEK5 EGFR 4553/4885MEN1 1766/4885KMT2A 2554/4885
US-10676438-B2 KCNQ2-5 channel activator KCNQ5, KCNQ2, KCNQ1 EGFR 4717/4885MEN1 1445/4885KMT2A 515/4885
US-20090149425-A1 Malononitrile compound as pesticides NR0B1, RTN4, OR10J3 EGFR 2255/4885MEN1 929/4885KMT2A 3120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.